切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2020, Vol. 13 ›› Issue (05) : 321 -327. doi: 10.3877/cma.j.issn.1674-6880.2020.05.001

所属专题: 文献

论著

维生素D对脓毒性休克导致急性呼吸窘迫综合征患者的干预价值研究
李娜1, 王美霞2,(), 周晋萌2, 刘虹2, 赵兰1, 姚哲放1, 王雪慧3   
  1. 1. 030001 太原,山西医科大学第一临床医学院
    2. 030001 太原,山西医科大学第一医院重症医学科
    3. 030024 太原,山西省心血管病医院重症医学科
  • 收稿日期:2020-01-15 出版日期:2020-10-31
  • 通信作者: 王美霞
  • 基金资助:
    山西省重点研发计划(指南)项目(201603D321066)

Intervention of vitamin D on acute respiratory distress syndrome caused by septic shock

Na Li1, Meixia Wang2,(), Jinmeng Zhou2, Hong Liu2, Lan Zhao1, Zhefang Yao1, Xuehui Wang3   

  1. 1. First Clinical Medical School, Shanxi Medical University, Taiyuan 030001, China
    2. Department of Critical Care Medicine, First Hospital of Shanxi Medical University, Taiyuan 030001, China
    3. Department of Critical Care Medicine, Shanxi Cardiovascular Hospital, Taiyuan 030024, China
  • Received:2020-01-15 Published:2020-10-31
  • Corresponding author: Meixia Wang
  • About author:
    Corresponding author: Wang Meixia, Email:
引用本文:

李娜, 王美霞, 周晋萌, 刘虹, 赵兰, 姚哲放, 王雪慧. 维生素D对脓毒性休克导致急性呼吸窘迫综合征患者的干预价值研究[J/OL]. 中华危重症医学杂志(电子版), 2020, 13(05): 321-327.

Na Li, Meixia Wang, Jinmeng Zhou, Hong Liu, Lan Zhao, Zhefang Yao, Xuehui Wang. Intervention of vitamin D on acute respiratory distress syndrome caused by septic shock[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2020, 13(05): 321-327.

目的

探索维生素D对脓毒性休克致急性呼吸窘迫综合征(ARDS)的干预效果。

方法

选取2017年6月至2019年6月入住山西医科大学第一医院重症监护室发生脓毒性休克导致ARDS的80例患者,根据25-羟维生素D水平分级分为维生素D正常组(17例,25-羟维生素D ≥ 50 nmol /L)和维生素D降低组(63例,25-羟维生素D < 50 nmol /L)。然后再根据25-羟维生素D水平的降低程度进一步将维生素D降低组分为维生素D缺乏组(35例,30 nmol /L ≤25-羟维生素D ≤ 49.9 nmol /L)和维生素D严重缺乏组(28例,25-羟维生素D <30 nmol/L)。采用随机数字表法将维生素D缺乏组患者分为A组(对照组,17例)和B组(干预组,18例),将维生素D严重缺乏组患者分为C组(对照组,14例)和D组(干预组,14例)。A、C组患者给予经胃管、肠内营养管补充淀粉胶囊0.5 g/d;B、D组患者给予经鼻胃管、鼻肠管补充阿法骨化醇软胶囊0.5 g/d,疗程均为7 d。记录所有患者的年龄、性别、25-羟维生素D、氧合指数、急性病生理学和长期健康评价(APACHE)Ⅱ评分、血管外肺水指数(EVLWI)、肺血管通透性指数(PVPI)及28 d死亡情况,采用Cox回归分析影响脓毒性休克致ARDS患者28 d病死率的危险因素。

结果

维生素D正常组和维生素D降低组患者25-羟维生素D [(57 ± 4)nmol /L vs.(33 ± 8)nmol /L]、氧合指数[(135 ± 25)mmHg vs.(114 ± 18)mmHg]、APACHEⅡ评分[(14.7 ± 1.6)分vs.(16.0 ± 2.0)分]、EVLWI [(11.4 ± 2.1)mL/kg vs.(14.5 ± 2.7)mL/kg]、PVPI [(3.61 ± 0.32)vs.(5.05 ± 0.68)]及28 d死亡情况(1/17 vs. 20 /63)比较,差异均有统计学意义(t = 11.448、3.872、8.864、5.097、8.409,χ2 = 4.626;P均< 0.05)。Cox回归分析结果显示,25-羟维生素D [相对危险度= 4.183,95%置信区间(1.787,10.594),P = 0.012]是脓毒性休克致ARDS患者预后的保护因素。且干预后,C、D组患者25-羟维生素D [(25 ± 4)nmol /L vs.(37 ± 4)nmol /L]、氧合指数[(152 ± 18)mmHg vs.(171 ± 13)mmHg]、APACHEⅡ评分[(12.8 ± 1.4)分vs.(11.0 ± 1.7)分]、EVLWI [(9.5 ± 0.9)mL /kg vs.(7.9 ± 1.4)mL /kg]及PVPI [(3.63 ± 0.28)vs.(2.95 ± 0.48)]比较,差异均有统计学意义(t = 7.493、3.246、3.016、3.420、4.373,P均< 0.05),而28 d死亡情况(6 /14 vs. 4 /14)比较,差异无统计学意义(χ2 = 0.622,P = 0.430)。

结论

维生素D降低在脓毒性休克致ARDS患者中普遍存在,且维生素D是脓毒性休克ARDS患者28 d病死率的保护因素,而补充维生素D可改善维生素D严重缺乏者ARDS的严重程度。

Objective

To explore the intervention effect of vitamin D on acute respiratory distress syndrome (ARDS) patients caused by septic shock.

Methods

From June 2017 to June 2019, 80 ARDS patients with septic shock in the Intensive Care Unit of the First Hospital of Shanxi Medical University were selected. Based on the 25-hydroxyvitamin D level, they were classified into a normal vitamin D group (17 patients, 25-hydroxyvitamin D ≥ 50 nmol/L) and a vitamin D reduction group (63 patients, 25-hydroxyvitamin D < 50 nmol/L). Then according to the decreased level of 25-hydroxyvitamin D, patients in the vitamin D reduction group were further divided into a vitamin D deficiency group (35 patients, 30 nmol/L ≤ 25-hydroxyvitamin D ≤ 49.9 nmol/L) and a severe vitamin D deficiency group (28 patients, 25-hydroxyvitamin D < 30 nmol/L). Using a random number table method, patients in the vitamin D deficiency group were divided into an A group (control group, 17 patients) and a B group (intervention group, 18 patients), and patients in the severe vitamin D deficiency group were divided into a C group (control group, 14 patients) and a D group (intervention group, 14 patients). Patients in the A and C groups were given 0.5 g/d starch capsule through the stomach tube and enteral nutrition tube, while patients in the B and D groups were given 0.5 g/d alfacalcidol soft capsule through the nasogastric tube and nasointestinal tube, all for 7 days. The age, sex, 25-hydroxyvitamin D, oxygenation index, acute physiology and chronic health evaluation (APACHE) Ⅱ score, extra vascular lung water index (EVLWI), pulmonary vascular permeability index (PVPI), and 28-d mortality of all patients were recorded, and risk factors influencing 28-d mortality of ARDS patients with septic shock were analyzed by Cox regression analysis.

Results

The 25-hydroxyvitamin D [(57 ± 4) nmol/L vs. (33 ± 8) nmol/L], oxygenation index [(135 ± 25) mmHg vs. (114 ± 18) mmHg], APACHE Ⅱ score [(14.7 ± 1.6) scores vs. (16.0 ± 2.0) scores], EVLWI [(11.4 ± 2.1) mL/kg vs. (14.5 ± 2.7) mL/kg], PVPI [(3.61 ± 0.32) vs. (5.05 ± 0.68)] and 28-d mortality (1/17 vs. 20/63) were statistically significantly different betwwen the normal vitamin D group and vitamin D reduction group (t = 11.448, 3.872, 8.864, 5.097, 8.409; χ2 = 4.626; all P < 0.05). Cox regression analysis showed that the 25-hydroxyvitamin D [relative risk = 4.183, 95% confidence interval (1.787, 10.594), P = 0.012] was a protective factor for the prognosis of ARDS patients with septic shock. After the intervention, the 25-hydroxyvitamin D [(25 ± 4) nmol/L vs. (37 ± 4) nmol/L], oxygenation index [(152 ± 18) mmHg vs. (171 ± 13) mmHg], APACHE Ⅱ score [(12.8 ± 1.4) scores vs. (11.0 ± 1.7) scores], EVLWI [(9.5 ± 0.9) mL/kg vs. (7.9 ± 1.4) mL/kg] and PVPI [(3.63 ± 0.28) vs. (2.95 ± 0.48)] were statistically significantly different between the C and D groups (t = 7.493, 3.246, 3.016, 3.420, 4.373; all P < 0.05), while the 28-d mortality was not statistically significantly different (6/14 vs. 4/14, χ2 = 0.622, P = 0.430).

Conclusions

The decrease of vitamin D is common in ARDS patients caused by septic shock, and vitamin D is a protective factor for their 28-d mortality. The supplementation of vitamin D may improve the severity of ARDS in patients with severe vitamin D deficiency.

表1 维生素D正常组和维生素D降低组脓毒性休克导致ARDS患者一般资料比较( ± s
表2 影响脓毒性休克致ARDS患者预后的多因素Cox回归分析
表3 A、B两组脓毒性休克致ARDS患者干预前后一般资料比较( ± s
表4 C、D两组脓毒性休克致ARDS患者干预前后一般资料比较( ± s
1
Rawal G, Yadav S, Kumar R. Acute respiratory distress syndrome: an update and review[J]. J Transl Int Med, 2018, 6 (2): 74-77.
2
Du F, Jiang P, He S, et al. Antiplatelet therapy for critically ill patients: a pairwise and bayesian network meta-analysis[J]. Shock, 2018, 49 (6): 616-624.
3
谢珂,林时辉,徐防. 急性呼吸窘迫综合征炎症微环境对调节性T细胞分化的影响[J]. 中国急救医学,2019,39(5): 491-496.
4
严一核,孙雪东,李智鑫,等. 急性呼吸窘迫综合征患者肺泡微环境对肺成纤维细胞生物学活性的影响[J/CD]. 中华危重症医学杂志(电子版),2018,11(3): 151-156.
5
杨伟杰,赵伟鑫,刘永亮,等. 维生素D受体研究进展[J]. 河南科技学院学报(自然科学版),2019,47(5): 46-51.
6
Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention[J]. Rev Endocr Metab Disord, 2017, 18 (2): 153-165.
7
Trongtrakul K, Feemuchang C. Prevalence and association of vitamin D deficiency and mortality in patients with severe sepsis[J]. Int J Gen Med, 2017 (10): 415-421.
8
Khoo AL, Chai L, Koenen H, et al. Translating the role of vitamin D3 in infectious disease[J]. Crit Rev Microbiol, 2012, 38 (2): 122-135.
9
修小莹,崔玉霞. 维生素D与儿童支气管哮喘的关系[J]. 贵州医药,2018,42(2): 167-169.
10
蒋凌志,许丹媛,杨志雄. 支气管哮喘患者血清25-(OH)D3、TGF-β1水平与气道重塑的关系[J]. 山东医药,2018,58(12): 54-56.
11
Park S, Lee MG, Hong SB, et al. Effect of vitamin D deficiency in Korean patients with acute respiratory distress syndrome[J]. Korean J Intern Med, 2018, 33 (6): 1129-1136.
12
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3)[J]. JAMA, 2016, 315 (8): 801-810.
13
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. JAMA, 2012, 307 (23): 2526-2533.
14
Herwanto V, Shetty A, Nalos M, et al. Accuracy of quick sequential organ failure assessment score to predict sepsis mortality in 121 studies including 1,716,017 individuals: a systematic review and meta-analysis[J]. Crit Care Explor, 2019, 1 (9): e0043.
15
Sasaki A, Shiraishi A, Nozaki S, et al. Acute physiology and chronic health evaluation Ⅳ probability of mortality is an intermediate variable, not a confounder[J]. Crit Care Med, 2020, 48 (3): e252-e253.
16
廖祥鹏,张增利,张红红,等. 维生素D与成年人骨骼健康应用指南(2014年标准版)[J].中国骨质疏松杂志,2014,20(9): 1011-1030.
17
王雪慧,刘虹,王美霞,等. 维生素D与脓毒性休克致器官功能障碍及预后的关系[J]. 中国新药与临床杂志,2019,38(8): 472-477.
18
孙丽琴,费扬,卢薇娜,等. 65岁以上老年人血清25-羟维生素D水平与代谢综合征的相关性分析[J/CD]. 中华危重症医学杂志(电子版),2018,11(4): 260-264.
19
Cookson MW, Ryan SL, Seedorf GJ, et al. Antenatal vitamin D preserves placental vascular and fetal growth in experimental chorioamnionitis due to intra-amniotic endotoxin exposure[J]. Am J Perinatol, 2018, 35 (13): 1260-1270.
20
沙影丽. 婴幼儿哮喘血清维生素D及T细胞亚群变化研究[D]. 长春:吉林大学,2016.
21
Nouari W, Ysmail-Dahlouk L, Aribi M. Vitamin D3 enhances bactericidal activity of macrophage against Pseudomonas aeruginosa[J]. Int Immunopharmacol, 2016 (30): 94-101.
22
Wang WY, Xu N, Yu XF, et al. Changes of extra-vascular lung water as an independent prognostic factor for early developed ARDS in severely burned patients[J]. J Burn Care Res, 2020, 41 (2): 402-408.
23
刘鸿飞,崔颖. 急性呼吸窘迫综合征患者血管外肺水指数和肺血管通透性指数变化对其预后的影响[J]. 内科急危重症杂志,2018,24(3): 261-262.
24
Kor DJ, Warner DO, Carter RE, et al. Extravascular lung water and pulmonary vascular permeability index as markers predictive of postoperative acute respiratory distress syndrome[J]. Crit Care Med, 2015, 43 (3): 665-673.
25
Ahmad S. Vitamin D for acute respiratory distress syndrome: sunshine or shade?[J]. Crit Care Med, 2018, 46 (12): 2064-2065.
26
Braun AB, Gibbons FK, Litonjua AA, et al. Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality[J]. Crit Care Med, 2012, 40 (1): 63-72.
27
Thickett DR, Moromizato T, Litonjua AA, et al. Association between prehospital vitamin D status and incident acute respiratory failure in critically ill patients: a retrospective cohort study[J]. BMJ Open Respir Res, 2015, 2 (1): e000074.
28
Dancer RC, Parekh D, Lax S, et al. Vitamin D defificiency contributes directly to the acute respiratory distress syndrome (ARDS)[J]. Thorax, 2015, 70 (7): 617-624.
29
Amrein K, Schnedl C, Holl A, et al. Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial[J]. JAMA, 2014, 312 (15): 1520-1530.
[1] 江雅婷, 刘林峰, 沈辰曦, 陈奔, 刘婷, 龚裕强. 组织相关巨噬素3 保护肺血管内皮糖萼治疗急性呼吸窘迫综合征的机制研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 353-362.
[2] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[3] 徐保平, 彭怀文, 喻怀斌, 王晓涛. 新型冠状病毒肺炎继发糖尿病酮症酸中毒合并肝门静脉积气一例[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(04): 250-255.
[4] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[5] 白若靖, 郭军. 维生素D对肺部疾病临床意义的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 659-662.
[6] 刘思含, 张静. 老年人血清铁与C 反应蛋白的比值及25-羟基维生素D3 与肾功能受损的关系研究[J/OL]. 中华肾病研究电子杂志, 2024, 13(05): 268-272.
[7] 房桂彬, 肖进, 傅光涛, 郑秋坚. 老年髋部骨折患者术后1年行走能力的影响因素分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 273-280.
[8] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[9] 杨东星, 沈鹏, 赵慧颖. 免疫球蛋白联合依库珠单抗治疗GBS 并发重度ARDS 患者一例[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 404-408.
[10] 韩俊岭, 王刚, 马厉英, 连颖, 徐慧. 维生素D 联合匹维溴铵治疗腹泻型肠易激综合征患者疗效及对肠道屏障功能指标的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 560-564.
[11] 董晟, 郎胜坤, 葛新, 孙少君, 薛明宇. 反向休克指数乘以格拉斯哥昏迷评分对老年严重创伤患者发生急性创伤性凝血功能障碍的预测价值[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 541-547.
[12] 宫平, 刘倩, 王啸, 袁会敏, 王维展, 王璞. 早期PI联合Pv-aCO2/Ca-vO2预测老年脓毒性休克的死亡风险[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 253-258.
[13] 傅新露, 李之岳, 卢丹. 妊娠合并结肠癌穿孔致脓毒症休克一例并文献复习[J/OL]. 中华产科急救电子杂志, 2024, 13(04): 227-231.
[14] 胡琴, 莫伟, 中国研究型医院学会出血专业委员会, 中国出血中心联盟护理专家委员会. 失血性休克急救护理专家共识[J/OL]. 中华介入放射学电子杂志, 2024, 12(03): 193-199.
[15] 詹维强, 李梦蝶, 涂玉玲, 郭艳, 芦乙滨, 史新格, 许明. 早期CRRT联合VA-ECMO治疗难治性心源性休克的临床效果[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 260-268.
阅读次数
全文


摘要